FOXP2 and gestational diabetes: On the basis of this hypothesis and detection of clinical samples, we established an in vitro cell model to evaluate the therapeutic role of miR-134-5p/FOXP2 in trophoblast cell dysfunction, hoping to provide a targeted protocol for GDM treatment.